210 related articles for article (PubMed ID: 24452316)
1. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.
Wolach O; Kuijpers T; Ben-Ari J; Gavrieli R; Feinstein-Goren N; Alders M; Garty BZ; Wolach B
J Clin Immunol; 2014 Feb; 34(2):163-70. PubMed ID: 24452316
[TBL] [Abstract][Full Text] [Related]
2. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
[TBL] [Abstract][Full Text] [Related]
4. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
5. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
6. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
7. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
8. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
Oikonomopoulou C; Goussetis E
Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
[TBL] [Abstract][Full Text] [Related]
10. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
11. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
12. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
13. Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.
Toribio-Dionicio C; Cubas-Guzmán D; Guerra-Canchari P; García-Sánchez V; Córdova-Calderón W
Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):33-37. PubMed ID: 33734873
[No Abstract] [Full Text] [Related]
14. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
Hsu AP; Sowerwine KJ; Lawrence MG; Davis J; Henderson CJ; Zarember KA; Garofalo M; Gallin JI; Kuhns DB; Heller T; Milner JD; Puck JM; Freeman AF; Holland SM
J Allergy Clin Immunol; 2013 Jun; 131(6):1586-93. PubMed ID: 23623265
[TBL] [Abstract][Full Text] [Related]
15. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).
Heimall J; Davis J; Shaw PA; Hsu AP; Gu W; Welch P; Holland SM; Freeman AF
Clin Immunol; 2011 Apr; 139(1):75-84. PubMed ID: 21288777
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
[TBL] [Abstract][Full Text] [Related]
17. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009-2018).
Xiang Q; Zhang L; Liu X; Wang S; Wang T; Xiao M; Zhao X; Jiang L
Scand J Immunol; 2020 Jun; 91(6):e12885. PubMed ID: 32248557
[TBL] [Abstract][Full Text] [Related]
19. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
20. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]